Predictive epigenomic biomarkers in rectal cancer patients receiving treatment
Ended Cooperative Agreement Awarded Last action
- Award ID
- R01CA171767
- Recipient
-
Saint John's Cancer Institute UEI RG2GTSYTHE73
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,894,464
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Place of performance
- Santa Monica, CA 90404, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$6,178 | |
| Amendment | $38,243 | |
| Amendment | $344,180 | |
| Amendment | $382,423 | |
| Amendment | $382,423 | |
| Amendment | $370,950 | |
| Amendment | $95,606 | |
| Original award | $286,817 |
Quick answers
Who received award R01CA171767?
R01CA171767 was awarded to Saint John's Cancer Institute by National Cancer Institute (National Institutes of Health) on April 1, 2013.
How much is award R01CA171767 worth?
$1,894,464 has been obligated on R01CA171767.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award